Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

June 01, 1995; Volume 47,Issue 6
  • You have access
    Analysis of selective binding epitopes for the kappa-opioid receptor antagonist nor-binaltorphimine.
    S A Hjorth, K Thirstrup, D K Grandy and T W Schwartz
    Molecular Pharmacology June 1995, 47 (6) 1089-1094;
  • You have access
    Expression of human copper/zinc-superoxide dismutase inhibits the death of rat sympathetic neurons caused by withdrawal of nerve growth factor.
    J Jordan, G D Ghadge, J H Prehn, P T Toth, R P Roos and R J Miller
    Molecular Pharmacology June 1995, 47 (6) 1095-1100;
  • You have access
    Cloning and stable expression of a cDNA encoding a rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 1.1) that catalyzes the glucuronidation of opioids and bilirubin.
    B L Coffman, M D Green, C D King and T R Tephly
    Molecular Pharmacology June 1995, 47 (6) 1101-1105;
  • You have access
    Paclitaxel (taxol) inhibits protein isoprenylation and induces apoptosis in PC-3 human prostate cancer cells.
    R Danesi, W D Figg, E Reed and C E Myers
    Molecular Pharmacology June 1995, 47 (6) 1106-1111;
  • You have access
    Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription.
    M Schwaninger, C Schöfl, R Blume, L Rössig and W Knepel
    Molecular Pharmacology June 1995, 47 (6) 1112-1118;
  • You have access
    N-methyl-D-aspartate receptors activate transcription of c-fos and NGFI-A by distinct phospholipase A2-requiring intracellular signaling pathways.
    L S Lerea, N G Carlson and J O McNamara
    Molecular Pharmacology June 1995, 47 (6) 1119-1125;
  • You have access
    Production and characterization of multiple antigenic peptide antibodies to the adenosine A2b receptor.
    N K Puffinbarger, K R Hansen, R Resta, A B Laurent, T B Knudsen, J L Madara and L F Thompson
    Molecular Pharmacology June 1995, 47 (6) 1126-1132;
  • You have access
    Alternatively spliced forms of the alpha subunit of the epithelial sodium channel: distinct sites for amiloride binding and channel pore.
    X J Li, R H Xu, W B Guggino and S H Snyder
    Molecular Pharmacology June 1995, 47 (6) 1133-1140;
  • You have access
    Methylation of mercaptopurine, thioguanine, and their nucleotide metabolites by heterologously expressed human thiopurine S-methyltransferase.
    E Y Krynetski, N F Krynetskaia, Y Yanishevski and W E Evans
    Molecular Pharmacology June 1995, 47 (6) 1141-1147;
  • You have access
    Cytochromes P450 of the 2D subfamily in rat brain.
    A Wyss, J A Gustafsson and M Warner
    Molecular Pharmacology June 1995, 47 (6) 1148-1155;
  • You have access
    Thrombin-mediated down-regulation of endothelin receptors in mesangial cells coincides with the down-regulation of neutral endopeptidase activity.
    C R Albrightson, M Pullen, H L Wu, G Dytko, L B Hersh and P Nambi
    Molecular Pharmacology June 1995, 47 (6) 1156-1163;
  • You have access
    Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells.
    M W Verghese, R T McConnell, J M Lenhard, L Hamacher and S L Jin
    Molecular Pharmacology June 1995, 47 (6) 1164-1171;
  • You have access
    Adenosine A1 receptor-mediated activation of phospholipase C-beta 3 in intestinal muscle: dual requirement for alpha and beta gamma subunits of Gi3.
    K S Murthy and G M Makhlouf
    Molecular Pharmacology June 1995, 47 (6) 1172-1179;
  • You have access
    Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor.
    Y X Pan, J Cheng, J Xu, G Rossi, E Jacobson, J Ryan-Moro, A I Brooks, G E Dean, K M Standifer and G W Pasternak
    Molecular Pharmacology June 1995, 47 (6) 1180-1188;
  • You have access
    Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin.
    P Granger, B Biton, C Faure, X Vige, H Depoortere, D Graham, S Z Langer, B Scatton and P Avenet
    Molecular Pharmacology June 1995, 47 (6) 1189-1196;
  • You have access
    Interpretation of binding curves obtained with high receptor concentrations: practical aid for computer analysis.
    S Swillens
    Molecular Pharmacology June 1995, 47 (6) 1197-1203;
  • You have access
    2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor.
    R A Wilcox, C Erneux, W U Primrose, R Gigg and S R Nahorski
    Molecular Pharmacology June 1995, 47 (6) 1204-1211;
  • You have access
    Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acid.
    H Safayhi, E R Sailer and H P Ammon
    Molecular Pharmacology June 1995, 47 (6) 1212-1216;
  • You have access
    Dual modulation of the gamma-aminobutyric acid type A receptor/ionophore by alkyl-substituted gamma-butyrolactones.
    K D Holland, G C Mathews, A M Bolos-Sy, J B Tucker, P A Reddy, D F Covey, J A Ferrendelli and S M Rothman
    Molecular Pharmacology June 1995, 47 (6) 1217-1223;
  • You have access
    Metabolism of ethanol to 1-hydroxyethyl radicals in vivo: detection with intravenous administration of alpha-(4-pyridyl-1-oxide)-N-t-butylnitrone.
    D R Moore, L A Reinke and P B McCay
    Molecular Pharmacology June 1995, 47 (6) 1224-1230;
  • You have access
    5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
    S Spadari, G Ciarrocchi, F Focher, A Verri, G Maga, F Arcamone, E Iafrate, S Manzini, A Garbesi and L Tondelli
    Molecular Pharmacology June 1995, 47 (6) 1231-1238;
  • You have access
    Involvement of divalent ions in the nitric oxide-induced blockade of N-methyl-D-aspartate receptors in cerebellar granule cells.
    L Fagni, M Olivier, M Lafon-Cazal and J Bockaert
    Molecular Pharmacology June 1995, 47 (6) 1239-1247;
  • You have access
    Cholinergic inhibition of slow delayed-rectifier K+ current in guinea pig sino-atrial node is not mediated by muscarinic receptors.
    L C Freeman and R S Kass
    Molecular Pharmacology June 1995, 47 (6) 1248-1254;
  • You have access
    Effects of interleukin-1 alpha on DNA repair in human ovarian carcinoma (NIH:OVCAR-3) cells: implications in the mechanism of sensitization of cis-diamminedichloroplatinum(II).
    M N Benchekroun, R Parker, M Dabholkar, E Reed and B K Sinha
    Molecular Pharmacology June 1995, 47 (6) 1255-1260;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 47, Issue 6
1 Jun 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Peptide Nanoformulations against the Tumor Microenvironment
  • Characterization of Vixotrigine
  • Dehydrocrenatidine Is a Novel JAK Inhibitor
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics